Acid Reflux And Heartburn Treatment In Brandon, FL

There’s no best reflux operation. There’s a right operation for a specific anatomy, and sometimes the right answer is no operation. Dr. Grandhige performs all four major anti-reflux procedures, which means the decision isn’t constrained by what’s familiar.

Fundoplication rebuilds the valve using your own stomach tissue. It isn’t one operation. Nissen is a full 360-degree wrap, Toupet a posterior 270, Watson an anterior 270, and Dor an anterior partial. The configuration is chosen from your manometry results before you’re in the operating room, because a weak esophagus cannot push food through a full wrap comfortably. It’s the most durable of the four, handles large hiatal hernias, and has decades of outcome data behind it. Operative time runs 1.5 to 2 hours, most patients go home the same day, and diet advances over 2 to 3 months. Dr. Grandhige has performed more than 600.

LINX is a ring of magnetic titanium beads that resists opening when stomach pressure rises, then opens when you swallow. Because it doesn’t wrap the stomach, most patients keep the ability to burp and vomit once early swelling settles, and gas bloating is less of a problem. One misconception is worth correcting: hernia size does not disqualify you from LINX, provided the hernia is repaired during the same operation. Motility is what decides. LINX needs an esophagus strong enough to push food through the resistance. Current devices are MRI compatible to 1.5 Tesla, and the device can be removed if needed. Dr. Grandhige has performed more than 600 and is one of the busiest LINX surgeons in the country.

TIF, or transoral incisionless fundoplication, is done entirely through the mouth with the EsophyX device. No abdominal incisions, 45 to 60 minutes, same-day discharge. The tradeoff is specific and non-negotiable: because it works from the inside, it cannot repair a hiatal hernia and does not address the diaphragm. The ASGE guideline on the diagnosis and management of GERD sets the boundary clearly, suggesting TIF for confirmed GERD with a hiatal hernia of 2 centimeters or less and a Hill grade I or II flap valve. Larger hernias and Hill grade III or IV point toward combined repair or surgical therapy. Dr. Grandhige has performed more than 200 TIF procedures and declines the ones that fall outside those criteria, including patients who are obese or who have Barrett’s esophagus, severe esophagitis or strictures.

RefluxStop restores the position of the gastroesophageal junction without encircling or compressing the esophagus. It’s being added to the practice following FDA approval in 2026. More on the timing below.

The procedure gets chosen through a six-step process, in this order:

1. Prove reflux is real. Objective pH testing, symptom correlation, and whether the reflux is acid, non-acid or bile. If reflux isn’t proven, no surgery is recommended regardless of how severe the symptoms are.
2. Map the anatomy. Hernia size and shape, esophageal length, and the relationship between stomach, diaphragm and esophagus.
3. Measure esophageal function. Manometry determines whether a full or partial wrap is safe, whether a magnetic device is appropriate, and whether surgery should be avoided.
4. Match symptoms to physiology. Which symptoms are very likely reflux, which are unlikely, and which are multifactorial. You’ll be told all three before any decision.
5. Weigh your priorities. Durability, medication elimination, the ability to burp and vomit, side-effect tolerance, reversibility. Preference refines the choice inside what’s medically safe. It doesn’t override anatomy.
6. Choose a procedure, or choose none. Observation and medical management stay on the table through the entire process.

Reflux surgery fixes reflux. It does not fix every symptom you walked in with, and any surgeon who suggests otherwise is setting you up to be disappointed by a technically successful operation.

Patients usually arrive with a long list: heartburn, regurgitation, chest discomfort, throat clearing, cough, hoarseness, bloating, nausea, fatigue, sleep disruption, bad breath, food intolerance. It’s natural to want one diagnosis to explain all of it. The body doesn’t cooperate. Heartburn and regurgitation may resolve completely while throat symptoms improve only partially and bloating persists from a separate mechanism.

The honest side effects, by procedure:

• Fundoplication makes it harder for acid to come up, which also makes it harder for air and food to come up. Bloating and difficulty vomiting are the two most common concerns. Whether those effects are temporary or permanent depends on the wrap type, which is why configuration is chosen from your motility data.
• LINX carries a higher rate of early swallowing difficulty and a small but real risk of longer-term dysphagia. Some patients sense the device. A reliable predictor: people who felt their Bravo pH capsule while it was in place often feel their LINX.
• TIF is the least durable of the four by design, at roughly a 2 percent failure rate per year, or about 20 percent per decade. It’s the best endoscopic option available, and it should be understood as an option that works for many years rather than a permanent repair.
• All four are functional operations. Like a joint replacement, they work well, they’re subject to wear, and they may need revision over a lifetime.

Timing matters for expectations too. Typical heartburn and regurgitation often resolve almost immediately. Throat symptoms from silent reflux commonly take 4 to 6 months to improve, and patients who aren’t told that in advance assume the operation failed at week six.

In appropriately selected patients with objectively proven typical reflux, adequate anatomy and good esophageal function, the practice reports greater than 95 percent success in symptom relief, elimination of daily reflux medication, and patient satisfaction. Outcomes run lower in patients with reduced motility, large or recurrent hernias, prior foregut surgery or previous bariatric surgery. Those conversations happen before a decision, not after.

Three things moved in the last two years that rarely appear in reflux content, and all three could change your options.

RefluxStop received FDA Premarket Approval on August 20, 2026. It’s an implant that holds the gastroesophageal junction in its natural position without encircling the esophagus, which is the design feature behind the swallowing difficulty, gas bloating and inability to belch that traditional wraps can cause. Approval rested on five-year data covering roughly 1,800 European patients. Implantica announced the approval and the start of US commercial activity, and the US launch began in September 2026 at the American Foregut Society annual meeting. Dr. Grandhige is a founding member of that society and is adding the procedure to the practice.

Vonoprazan is a different class of medication. Sold as Voquezna, it’s the first potassium-competitive acid blocker approved in the United States, cleared in November 2023 for erosive GERD and in July 2024 for heartburn associated with non-erosive GERD. It blocks acid by a different mechanism than a PPI, doesn’t need acid to activate, and can be taken with or without food. It’s still acid suppression. It will not strengthen a sphincter or repair a hernia. If you’ve never been offered it and medication is your preferred path, it’s a reasonable question for your prescribing physician.

The ASGE guideline now names specific numbers for TIF candidacy. Hernia of 2 centimeters or less, Hill grade I or II, confirmed GERD. It also asks that endoscopy reports document hiatal hernia dimensions using Hill grading rather than describing them loosely. If you’re being offered an incisionless procedure, ask whether your hernia was measured and what your Hill grade is. That single question filters out a large share of the cases that go badly.

Medically reviewed by Gopal Grandhige, MD, FACS. Board-certified general surgeon. BS, Johns Hopkins University. MD, University of Michigan, Ann Arbor. General surgery residency and fellowships in burn and critical care and in foregut and minimally invasive surgery, Yale-New Haven Hospital. Founding member, American Foregut Society. Member, Society of American Gastrointestinal and Endoscopic Surgeons. Fellow, American College of Surgeons. Practicing foregut and anti-reflux surgery in Tampa Bay since 2009. Board certification can be verified through the American Board of Surgery, and Florida licensure through the Florida Department of Health.

This page is educational and is not a substitute for individual medical evaluation.